DI
GILD icon

Disciplined Investors’s Gilead Sciences GILD Stock Holding History

Disciplined Investors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$426K Buy
3,057
+18
+0.6% +$2.52K 0.25% 80
2025
Q4 		$373K Buy
3,039
+107
+4% +$13K 0.24% 77
2025
Q3 		$325K Sell
2,932
-90
-3% -$10.2K 0.23% 88
2025
Q2 		$335K Buy
3,022
+23
+0.8% +$2.45K 0.26% 80
2025
Q1 		$336K Buy
2,999
+10
+0.3% +$1.03K 0.3% 71
2024
Q4 		$269K Buy
+2,989
New +$269K 0.26% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Disciplined Investors's GILD Position: Q1 2026 in Review

Disciplined Investors increased its Gilead Sciences (GILD) stake by 0.59% in Q1 2026, buying an estimated $2.52K and bringing the position to 3,057 shares worth $426K. The position accounts for 0.25% of the portfolio, ranked #80.

Disciplined Investors first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Disciplined Investors held 3,057 shares of Gilead Sciences worth $426K as of Q1 2026.
  • Disciplined Investors bought 18 Gilead Sciences shares in Q1 2026, an estimated $2.52K.
  • Gilead Sciences made up 0.25% of Disciplined Investors's portfolio in Q1 2026, its #80 holding.
  • Disciplined Investors first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Disciplined Investors's 13F filing for Q1 2026, filed 12 May 2026.